Ashwagandha can help fight COVID-19, claims studyMay 18, 2020 19:13
Ayurvedic herb Ashwagandha can be an effective therapeutic and preventive drug against the COVID-19 infection, a collaborative research by IIT-Delhi and Japan's National Institute of Advanced Industrial Science and Technology has found.
The natural compounds from Ashwagandha and Propolis have the potential to be an effective novel coronavirus preventive drug, according to the research team.
"The researchers targeted the main SARS-CoV-2's enzyme for splitting proteins, known as the main protease (Mpro), that plays a key role in mediating viral replication. This is an attractive drug target for this virus, and as humans don't naturally have this enzyme, compounds that target Mpro are likely to have low toxicity," said D Sundar, head of the Delhi Indian Institute of Technology's Biotechnology department.
"The findings may not only connect to save time and cost required for screening for anti-COVID-19 drugs, but may also offer some preventive and therapeutic value for the management of fatal COVID-19 pandemic, and hence, warrant prioritized validation in the laboratory and clinical tests," he said.
The drug's development may take some time, and in the current scenario, these natural resources -- Ashwagandha and Propolis -- can offer some preventive or even therapeutic value, according to Sundar.
He said that "although these are easily available and affordable, one has to be cautious about the content of bioactive ingredients. CAPE, while is a major component of propolis, its amount and stability are critical factors that could be managed by generating its complex with cyclodextrins".
"Withanone, on the other hand, varies with geography, parts and size of the Ashwagandha plant. So, in order to acquire or appreciate particular effects, we must use the right and quality-controlled resource and extracts," Sundar said.
The government has also initiated a study on whether Ashwagandha can be an alternative to anti-malarial drug Hydroxychloroquine (HCQ) as a potential COVID-19 preventive.
The study is being carried out by a group of scientists and researchers from the Ministry of AYUSH, the Ministry of Health and Family Welfare, the University Grants Commission and the Indian Council of Medical Research.
"While new line of drug and vaccine development have been initiated worldwide, in the current scenario of high infected numbers, severity of the disease and high morbidity, repurposing of the existing drugs are heavily explored by recruiting integrative genomics and bioinformatics research tools," Sundar said. -- PTI
Go First crisis pushes airfares higher, staff face uncertain times
From a surge in airfares to rattled aircraft lessors to thousands of employees staring at uncertainty, it has been a month of continued turbulence since cash-strapped Go First suspended flights from May 3. As the government and other...
Delhi riots: Man gets 7-yr jail term; father 3 yrs for not guiding son well
Additional sessions judge Pulastya Pramachala was hearing two cases against Mithhan Singh and his son Jony Kumar who were convicted of various offences, including those under IPC Sections 147 (rioting) and 436 (mischief by fire or...
Man missing for 33 years says goddess called him away, she sent him back
In a strange incident, a man who had gone missing some 33 years ago returned to his home in Rajasthan's Alwar much to the astonishment of his family who had stopped believing that he could be alive and had even got a death certificate...